psychiatry for lawyers .com
  home page The Author Reports contact us  
 
Introductory
 classification

 definition

 FAQs

 glossary

 psychiatric injury- medical

 treatment: general aspects

Medicolegal
 assessment process

 diagnosis & function

 causation

 forensic

 Mental Health Act

 psychiatric negligence

 psychiatric negligence 2

 psychiatric injury- legal

 psychiatric injury- legal 2

 capacity



Dr David Gill Dr Gill is an NHS Consultant, with a medico-legal practice.
psychiatric negligence

print view

ACKNOWLEDGEMENTS

This chapter is based on a chapter of the same name which I wrote with Maggie Bloom, barrister, Hardwicke Chambers, for Clinical Negligence, 4th edition, ed. Powers, Harris and Barton, London: Tottel 2008.

I am most grateful to my co-author and the editors and publishers for permission to use this material.

INTRODUCTION

The interaction between the law and psychiatry has always been complex. The present chapter attempts to cover those aspects of psychiatric practice most relevant to the clinical negligence practitioner:

(1) development and present state of psychiatric services;
(2) classification of psychiatric disorders;
(3) Treatments for psychiatric disorders;
(4) Mental Health Acts 1983 and 2007;
(5) Common areas of psychiatric negligence;
(6) Relation between complaints process and negligence;
(7) Group litigation;
(8) Mental Capacity Act 2005; and
(9) Psychiatric injury/nervous shock.

THE NATURE OF PSYCHIATRY

Much ink could be spilt on an attempt to define psychiatry, but in an article about negligence it seems more sensible to concentrate on psychiatric services. For present purposes, psychiatric services are taken as those specialist services, mainly in secondary care, for patients with mental health problems, to which they are (usually) referred by their GP, or some other agency. Psychiatric conditions also form, of course, a substantial part of the workload of general practice, and they also occur in all departments of the general hospital. Independent healthcare providers and non-governmental organisations also figure increasingly. These important additional aspects of psychiatric services will be discussed further below.

Current mental health care provision

It is natural to a psychiatrist to start a chapter about psychiatric negligence by writing about hospitals. But psychiatric services are no longer synonymous with psychiatric hospitals or beds. Psychiatric services are now predominantly delivered outside hospitals. For example, an episode of illness which formerly would have led to inpatient admission may now very well be dealt with ‘in the community’, by a Crisis and Home Treatment Team. However, starting with some description of psychiatric hospitals is probably still appropriate, as the more seriously affected patients, whose care is presumably most likely give rise to allegations of negligence, will likely still have substantial portions of that care delivered in hospital.

History of mental health care provision

It is impossible to understand the present configuration of mental health services, and the way in which they are developing, without some historical background. Controversy about imperfections in mental health care service provision is in fact nothing new. In the 18th and early 19th century, there was concern over the lack of provision for ‘pauper lunatics’, who were seen as inappropriately accommodated and maltreated, for example in jails or workhouses. There was also a series of scandals concerning the treatment of better off patients in the private ‘madhouses’ of the day, regarding poor treatment or misappropriation of property or other abuses.

(See Gill D B ‘A commission of lunacy, mad doctors, and happy hunting’ (1993) BMJ  307(6919): 1603–1606 for an account of a well-observed fictional episode befalling Surtees’s Mr Jorrocks.)

A series of Lunacy Acts to regulate such matters followed, but these pale beside the astonishing outbreak of sustained social conscience which produced the Asylum Movement of the 19th Century.

Each county had its own asylum, mostly built by public subscription in the 19th century. In other words, they were largely paid for by individual charitable gifts from local inhabitants, motivated at least in part by peer pressure, that is, a desire to ensure that provision for the mentally ill in their area was as good as that in other counties. These asylums dominated the development of psychiatric services for the next 150 years or more. As the then Minister of Health, Enoch Powell, famously put it as late as 1961,

‘There they stand, isolated, majestic, imperious, brooded over by the gigantic water-tower and chimney combined, rising unmistakable and daunting out of the countryside – the asylums which our forefathers built with such immense solidity to express the notions of their day.’

However, he also, in the same speech, foretold correctly – though this is less often quoted – that ‘the institutions themselves are doomed’.

In the early years of the asylums, there was therapeutic optimism, through the medium of work (and religion) (and music: Elgar was the Bandmaster at Powicke Hospital, near Worcester).

One downside, however, was the implanting of a presumption in our culture that, if someone developed mental health problems, that necessarily meant that he had to go – or be taken – to a hospital, likely distant and strange. This presumption is only now in the last 20 years or so being challenged by the idea that persons with such problems could, indeed should, be looked after at or near home if possible.

The asylums are now almost all closed (at any rate in England and Wales, though some cling on in Scotland, Ireland and the dominions). These were substantial buildings, typically with large farms, on which the patients did actual work, as a real form of occupational therapy. This probably benefited their wellbeing in many cases. At their height, they had huge numbers of beds, but a series of scandals in the 1960s and 1970s, in combination with the then fashionable ‘anti-psychiatry’ movement, hastened a secular decline in bed numbers which had been in train since the Second World War.

The first step, from about the 1950s, in the move away from the asylums was the provision of outpatient services. At the time, unbelievable as it may now seem, it was a new departure for psychiatrists to practice outside their hospitals. Inpatient bed use remained heavy, and individual stays often protracted.

From the 1960s and 1970s, the main further development was the provision of psychiatric services, including inpatient wards, on the same site as District General Hospitals. This tended to mean in local towns, rather than in the countryside where the asylums usually were. This has been later followed by the development of Community Mental Health Services, with staff working outside hospitals, that is ‘in the community’.

The process of asylum closure gathered pace. But a number of well-publicised cases gave rise to concern about whether patients, especially long-stay patients who might have lived in the hospital for many years, were being adequately provided for outside. There were legitimate concerns about whether a patient being moved from a large hospital to accommodation outside would have the care and facilities necessary, and traditionalists did look back with nostalgia to the better aspects of the old system. The fact of the matter however is that the vast majority of patients were resettled adequately and, when asked, preferred their new circumstances.

Although asylums were provided largely from individual charity for the benefit of patients, they had been taken over by the NHS in 1948. Unfortunately, the capital from the sale of these by now very valuable assets was not ringfenced, and went neither to the original founders, nor to specifically psychiatric services, but disappeared into state coffers. As an elderly Macmillan said about the public utilities, psychiatric patients have had their family silver sold, but did not benefit financially from the proceeds.

NHS mental health services

Most mental health problems are minor and self-limiting, and are dealt with in primary care, but if they are protracted or severe the patient may be referred to specialist mental health services. The main providers of mental health care remain NHS trusts. Most are separate from acute hospital trusts, though some ‘unitary trusts’ do exist.

In many cases, mental health trusts have amalgamated with those parts of local authority social services which have historically also dealt with mental health patients, through the provision of social workers and other facilities. Often, the local authority’s social care responsibilities are delegated to the resulting Trust, which may be styled a ‘Partnership Trust’.

A typical mental health Trust will have an adult psychiatric inpatient unit or units, usually with separate wards for the elderly. It will run a number of Community Mental Health Teams, each covering a defined patch, based on the patient’s address or registered GP. There will be other resources, such as Day Centres or Day Hospitals, though the details of provision vary greatly from area to area.

The provision of services in the community is constantly changing; the influence of central planning seems to have increased over the past 10 years. The ideas of the Sainsbury Centre for Mental Health have been influential.

The development of specialised teams has been encouraged – these include:

(1) Assertive Outreach, who have smaller case loads, specifically looking after patients, who tend to drop out of follow up, and therefore have worse outcomes, to try to improve their care and keep them out of hospital (so-called revolving door syndrome).

(2) Crisis and home treatment, whose remit is to look after patients, who are becoming acutely unwell, so as to try to prevent inpatient admission, or promote early discharge. They will use a package of measures such as frequent home visits, supervised administration of medication, promotion of attendance at day hospital, etc.

(3) Early intervention, whose remit is to identify younger patients in the early or so-called prodromal phase of the development of serious mental illness such as schizophrenia, and through intensive treatment to try to prevent these patients going on to develop the full-blown illness.

(4) Eating disorder, specialising in patients with anorexia, bulimia.

(5) Forensic psychiatry, offering a variety of services, including assessment of individual patients, caring for a caseload of their own, and prison inreach, court diversion, etc

(6) Child and adolescent, offering an almost entirely community-based service, working closely with paediatrics and schools.

(7) Learning disability, again, these days almost entirely community-based, accessing a variety of resources including day centres and workshops.

Each of these teams will be multidisciplinary: it will include a consultant psychiatrist, either on a full-time or sessional basis, a psychiatric junior doctor, administrative support, and a mixture of predominantly community psychiatric nurses and social workers, usually also with some input from occupational therapy and psychology.

At the time of writing, the vogue for these multiple teams seems to be starting to pass. They have all been formed, of course, out of ‘existing resources’, and the view seems to be gaining ground that there could be efficiency savings or ‘economies of scale’ in re-combining some of these teams.

‘Foundation Trusts’ have greater autonomy, and may bid for work outside their existing boundaries. Their budget from government is more protected, but they have limited borrowing powers and are thus, at any rate at present, dissimilar from commercial businesses.

Non-NHS mental health services

Many other types of body also provide mental health services, including:

(1) hospitals and clinics in the independent sector, for-profit and otherwise; and

(2) charities and other NGOs, for example providing day centres.

It is likely that political changes will lead to further changes in how services are provided. In future, organisations other than NHS Trusts, whether commercial or not-for-profit, may contract with purchasers (currently known as Primary Care Trusts, or PCTs) to provide clinical services. (It is of course already very common for non-clinical services (catering, cleaning, etc) to be contracted out.) These changes seem likely to proceed more quickly in England, than in Scotland, Wales and Northern Ireland.

Complexity may be the order of the day in future; for example, a service might say NHS ‘on the tin’ but be provided by a private company or NGO under contract. It is likely to be important for purchasers and providers of services to have measurable standards, and mechanisms for ensuring that they are maintained.

Structural problems in current mental health services

The post-asylum era has been associated with long-term shortage of resources in mental health services, which continues to date. Bed closures have continued, and bed numbers have probably now gone below an optimum level. It is common for bed occupancy to exceed 100 per cent in the NHS, and spillover into non-NHS beds is common.

This all leads to acute psychiatry having to be practiced in highly pressured circumstances, with pressure from administrators to avoid admissions and ‘leave beds’ (the bed of a patient who has been sent home for a period of leave to see how he does prior to discharge) having to be used. It is in such circumstances that adverse outcomes are more likely. These organisational factors, as well as clinical error, will need to be assessed and taken into account in any investigation thereof.

Responsibilities of organisations providing services

Before moving on to matters concerning the clinical care of individual patients, where possible negligence by a health professional may be at issue, it is important to remember that organisations also have to meet standards. For example:

(1)    access to services – the NHS Act and other legislation and regulations may give a patient rights to care from NHS and social services; and

(2)    various ‘watchdogs’ supervise health and social care providers, including CHI, the Commission for Health Improvement, and the Mental Health Act Commission.

The reported performance of an organisation according to such yardsticks could be relevant to a negligence claim.

ORGANISATION OF PSYCHIATRY, TRAINING OF PSYCHIATRISTS, FIELDS OF PRACTICE

When the last edition of Clinical Negligence was published, the training of psychiatrists was firmly in control of psychiatrists themselves, through the Royal College of Psychiatrists, and the specialty retained considerable power in the organisation and administration of mental health services. For good or ill, psychiatrists have lost power in both areas.

Government has established the Postgraduate Medical Education and Training Board (PMETB), to oversee training and the issuing of Certificates of Completion of Specialist Training. This has led to concerns that Government’s need to ensure a sufficient number of trained consultants has caused the standard of training to be watered down. It is clear that consultants are now being appointed whose length and breadth of training is less than was previously the case.

For UK medical graduates, the main route to specialist training in psychiatry continues to consist of doing junior training positions in the speciality, combined with studying for the membership of the Royal College of Psychiatrists, the recognised postgraduate diploma in the specialty. This is followed by competitive interview for a position as a specialist registrar, which, after approximately three years, subject to assessment, leads to eligibility to be appointed as a consultant psychiatrist.

The names of the positions have changed; previously, pre-MRCPsych trainees were predominantly senior house officers (SHOs), and post-MRCPsych trainees on programmes of specialist training were known as senior registrars. Nowadays, they are denoted, more cumbersomely, ST1-3, for SHOs, and ST4-6, for senior registrars. (‘ST’ means specialty trainee, and the numbers refer to the years of training).

Other routes to consultant appointment have opened up. Psychiatrists from EU countries who can demonstrate eligibility to consultant appointment in their country of origin are now eligible for NHS consultant appointments, and many such appointments, notably of colleagues from Eastern Europe, have in fact been made. Also, it has been made possible for psychiatrists who have worked for some years at senior but sub-consultant levels, such as Associate Specialist, to apply to PMETB for a Certificate of Eligibility for Specialist Registration; if they can demonstrate appropriate experience and training, they may be awarded the Certificate, which permits application for Consultant posts.

Overall, therefore, since the last edition of Clinical Negligence, there has been an increase in the number of NHS consultant psychiatrists; training has changed to be shorter and more focussed on the needs of the NHS, but has inevitably been diluted somewhat. Some middle-grade UK psychiatrists and some European colleagues, who have not followed the traditional MRCPscyh training route, have nevertheless been made eligible to consultant appointment. Secular decline in the authority of the consultant within organisations has continued.

Every patient in the NHS would previously have had a consultant psychiatrist at least nominally in charge of his care. This will still apply if he is an inpatient or attending outpatients, even if he is only seeing a trainee (ST1-6, speciality trainee covering the grades formerly known as SHOs and Registrars) or a non-training sub-consultant grade (these are permanent positions, Staff Grade and Associate Specialist, the latter the more senior). However, patients may these days be seen by CMHT members only, and not seen by (or their case even discussed with) a psychiatrist.

The GMC has issued guidance on working with teams, which says, broadly speaking, that the consultant is not responsible for adverse outcomes in patients seen only by other non-medical members of his team.

SPECIALISMS WITHIN PSYCHIATRY

The College recognises the following specialist areas:

(1) academic;
(2) addictions;
(3) child and adolescent psychiatry;
(4) forensic psychiatry;
(5) general and community psychiatry;
(6) liaison psychiatry;
(7) psychiatry of learning disability;
(8) psychiatry of old age;
(9) psychotherapy; and
(10) rehabilitation and social psychiatry. 

The largest speciality is general adult psychiatry; often appointments may be with a ‘special interest’, for example, half general adult and half liaison.

REVALIDATION AND RELICENSING

Partly in response to the crimes of Harold Shipman, the Department of Health, with the Royal College of Psychiatrists and NHS Trusts, has put in place processes to try to check that doctors in post are up-to-date and safe. Originally, this was planned to lead to ‘revalidation’ to continue practice, or not, as the case might be. Revalidation seems to have been dropped, at least for the time being, but the process continues. It has three parts:

(1) a programme of Continuous Professional Development (CPD), which requires psychiatrists to maintain, develop and remedy any deficits in their knowledge and skills relevant to their professional work;

(2) job planning; and

(3) appraisal.

Continuous Professional Development (CPD) is the responsibility of the individual consultant. He must meet with his peers and agree a Personal Development Programme (PDP), which is registered with the Royal College of Psychiatrists, and which sets specific learning targets for the year. At the end of the year, the completed plan is submitted to the College on a self certification basis, though random checks are carried out to make sure that the information, for example about courses attended, is accurate.

Job planning involves agreeing a timetable and objectives with the NHS Trust; it is carried out with the consultant’s medical manager (Lead Clinician or Medical Director, the precise terms vary) in the form of an annual meeting. It represents the NHS’s input into the process.

Appraisal is the final link in this chain. If the consultant has an agreed job plan, and his PDP is up-to-date, he can have an interview with an approved Appraiser from his Trust, as a result of which he is regarded as having been appraised.

It seems doubtful whether this somewhat toothless process would stop another Shipman, who apparently had many unsolicited thank you letters from patients. However, it is to be hoped that the process will help identify struggling colleagues at an early stage.


CLASSIFICATION OF PSYCHIATRIC DISORDERS

In psychiatry, it is unusual for there to be a single, well-understood cause of illness. There are a few exceptions, for example Alzheimer’s Disease, which is caused by physical degeneration of specific cells in the brain, leading to dementia, and Down’s Syndrome, where the person is born with three copies of chromosome 21, instead of two, leading to learning disability.

In the vast majority of mental disorders, however, there is no single clear cause. Even in the examples given, the precise mechanism whereby the physical or chemical abnormality gives rise to the clinical features is not completely understood. It follows therefore, that classification of mental disorder cannot be based on cause alone. Current international systems of classifying psychiatric illness such as DSM or ICD (see below) recognise this. They are essentially descriptive, and do not make assumptions about the presumed causes of the various illnesses. They are the cumulative result of many years of research and observation, and refinement through successive editions. They represent the collective opinions of experts about how the various categories within them can best be codified so as to fit as closely as possible the observed patient data.

DSM stands for Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition, known as DSM-IV, of the American Psychiatric Association. ICD stands for International Classification of Diseases, 10th Revision, known as ICD10. It is produced by the World Health Organisation, and is the official classification for the rest of the world, including the UK NHS. ICD10 is free online at http://www.who.int/classifications/apps/icd/icd10online/. DSM IV is available by subscription only, though unofficial versions do exist on the internet.

DSM vs ICD

Until the publication of DSMIII in 1980, US psychiatry, as previously indicated, was heavily influenced by Freudian and other psychoanalytic theories. Although of continuing interest to many, these theories are now agreed to be without scientific basis. DSM since then has ‘caught up’ with ICD in eschewing theory in favour of observation. It has gained in influence relative to ICD, possibly outstripping it in certain aspects, such as its multiaxial system (see below). DSM has also brought to prominence now-familiar terms such as ‘major depression’ and ‘PTSD’. Unlike ICD, which has just one ‘axis’ on which to code for mental disorder, DSM has 5 axes.

(1) Axis I: mental illnesses, an illness being defined as a state of impaired health with a clear onset following a period of normal function.

(2) Axis II: for recording (in the jargon, ‘coding’) the presence or absence of personality disorder(s) and learning disability (the latter was formerly called mental handicap or retardation); here, the abnormalities are permanent, and are apparent from adolescence or earlier.

(3) Axis III: Physical health problems.

(4) Axis IV: Psychosocial and Environmental Problems ‘is for reporting psychosocial and environmental stressors that may affect the diagnosis, treatment, and prognosis of mental disorders.’

(5) Axis V: Global Assessment of Functioning Scale ‘is for reporting the clinician's judgement of the individual's overall level of functioning and carrying out activities of daily living. This information is useful in planning treatment and measuring its impact, and in predicting outcome.’

Both classifications are regarded as valid for UK use. The ICD is the official classification for the UK NHS. It would not be generally accepted that one was better than the other for medicolegal purposes.

Caveats concerning DSM and ICD

These systems are guides only, describing ‘conditions coming to the attention of psychiatrists’. They are designed to summarise the assessment of the clinician, and to improve research and communication. They were not designed specifically for medicolegal use. They are not intended for lay use; they are not ‘cookbooks’, which dispense with the need for the psychiatric expert, any more than a collection of law books makes the services of a lawyer unnecessary. Thus, ICD and DSM are only properly used when they are interpreted by the seasoned clinician in the light of experience and expertise.

‘Best estimates’ rather than immutable scientific truths, there are differences between DSM and ICD, and between successive editions. They are ultimately no more than continually developing consensus statements of committees of researchers, but nevertheless do form a useful summary of the ‘state of the art’. Real patients seldom fit with complete neatness into the categories; indeed, patients may have more than one diagnosis, as the categories are not mutually exclusive.

Psychosis vs neurosis

Psychosis vs neurosis is another key concept in understanding the classification systems.

Psychosis

In psychosis (eg, schizophrenia), the patient has lost touch with reality. They experience delusions (unshakeable false beliefs) and/or unreal perceptions (eg, hallucinations such as hearing voices when no-one is around). The connections between their thoughts may be disrupted (‘formal thought disorder’). This is a severe illness, and approximates to the lay idea of ‘madness’. The patient does not realise that they are unwell (‘lacks insight’). Psychosis due to mental illness is sometimes termed ‘functional’, to distinguish it from ‘organic’ psychosis, which refers to psychotic states due to defined physical factors, such as drug intoxication or withdrawal (eg, delirium tremens in the case of alcohol). ‘Psychosis’ and ‘psychotic’ are still ‘respectable’ terms, widely used in clinical practice and in the ICD and DSM.

Neurosis

Neurosis, by contrast, is generally a less severe and much more common state. The patient is free from delusions and hallucinations – they know that their worries or depressive thoughts, for example, are excessive for the reality of the circumstances, and therefore recognise them as irrational. The vast majority of cases of anxiety and depression are of this type.

Use of terms such as ‘neurotic’ or ‘neurotic depression’ is less frequent because of the pejorative connotations the word has accquired in lay use. (This is a frequent occurrence in psychiatry; ‘paranoid’ is the latest escapee from the textbooks to the street. Even ‘lunatic’ was originally a technical term.) Accordingly, the word neurotic or neurosis would not be used frequently in clinical or medicolegal practice. The distinction between psychotic and non-psychotic states remains vitally important, however, but normally, the presence of psychosis will be made clear.

The word ‘neurosis’ still occurs in the ICD, though not the DSM, as part of the rather unwieldy title ‘Neurotic, stress-related and somatoform disorders’.

Available therapies

Modern psychiatry make use of a range of treatments, most of which are reasonably well-founded in evidence. As usual, the evidence base is stronger for specific types of medication or psychological treatment, rather than for broader questions of service delivery such as hospital admission.

Medication

Medication is probably the mainstay of psychiatric treatment, not because it is the only effective treatment, but it is the most readily available; non-drug treatments typically depend on the involvement of highly trained staff, who are usually in short supply and may not be available, especially at short notice. Psychiatric medications can be grouped together under the term ‘neuroleptics’, although it is less used these days. The main types are set out below.

Antidepressants

Antidepressants are probably the most widely prescribed, especially in general practice. Probably the best known is Prozac, the trade name for fluoxetine, which was one of the first SSRI antidepressant drugs available. Such drugs have been very widely prescribed, and have made enormous sums for the manufacturers. Concern has been expressed (see below) that side-effects from SSRIs (such as agitation in the early stages of treatment, with possible increase in risk of suicide) have been downplayed by the drugs companies, and also that the heavy involvement of the companies in psychiatric research may have led to changes in the way psychiatric practice has developed. This may have amounted to a moving of the goalposts in favour of more frequent diagnosis of depression, and consequent promotion of prescription of antidepressant medication.

Tricyclic antidepressant drugs, the ‘previous generation’ before the SSRIs, remain available. They are probably more effective, especially in severe cases, but at the disadvantage of being potentially toxic in overdose. Obviously, this is a potential cause for concern if they are being prescribed to patients with a risk of suicide (and all patients in mental health services have an elevated risk of suicide, compared with that of the general population). However, a patient determined upon suicide has a variety of other easily available methods, for example, purchase of paracetamol from a shop. Prescribing tricyclics is not in itself, therefore, contra-indicated in patients with, for example, severe depression. It will be appropriate if the drug is considered as the best one for the condition being treated, and if it is combined with appropriate risk assessment.

Now little used, the monoamine oxidase inhibitors or MAOIs are a group of powerful antidepressants, which have an unusual dietary restriction, namely that the patient has to avoid an eclectic group of foodstuffs including yeast, cheese, broad bean pods and Chianti. These have in common that they contain tyramine, which can cause high blood pressure, if combined with MAOIs. If unchecked, this could proceed to the patient having a stroke. Although the risks are actually very low, these unusual matters invariably worry patients, and MAOIs are underused as a result, which is regrettable as they are sometimes effective when other drugs have failed.

Major tranquillisers

Also known as antipsychotics, major tranquillisers, as the name suggests, are mainly used in psychosis, for example schizophrenia, paranoid psychosis, mania and psychotic depression. The first generation of these drugs, typified by chlorpromazine and haloperidol, produced some astonishing improvements in long institutionalised patients when they were first introduced in the 1950s, to the extent of allowing many of these patients to leave hospital. At this stage, they tended to be used in low doses.Subsequently, there was a tendency to try the use these of these drugs in higher doses, in the remaining patients who had not responded; there was little further improvement, even on very excessively high doses, which tended to produce side-effects such as weight gain and Parkinson like states (extrapyramidal side effects). This is how the older antipsychotics got their bad reputation.

However, they remain an excellent treatment in moderate doses, when they often produce few side-effects.

More modern, and much more expensive antipsychotic drugs, the so-called ‘atypicals’, such as olanzepine and risperidone, are widely prescribed; initially, as with all new drugs, they were thought to have few or no side-effects, but 10 years on, the adverse effects are becoming clearer, particularly weight gain and diabetes, and risk of stroke in the elderly.

Antipsychotic drugs are available in long acting injection form, so called ‘depot’ medication, which is very useful for patients who are not reliable at taking tablets (poor ‘compliance’ or, to use a more recent word, ‘concordance’).

Anticholinergic drugs

Anticholinergic drugs such as procyclidine are helpful in combating Parkinsonism due to antipsychotic drugs.

Mood stabilisers

Mood stabilisers such as lithium and a variety of anticonvulsants drugs including carbamazepine and valproate are used in bipolar affective disorder (formerly known as manic depressive psychosis), where, if taken regularly, they reduce the severity and frequency and duration of episodes of mood disorder. Problems surrounding lithium treatment are covered in more detail below: the level of the drug in the blood needs to be monitored by regular blood tests, as also do thyroid and kidney function. Lithium has a bad name for adverse effects, particularly kidney damage, mainly because of historical use in high doses with poor monitoring; negligence cases have arisen for this. In modern use, with proper monitoring and more moderate doses, adverse effects are rare.

Anticonvulsants

Anticonvulsants (especially in women of child bearing age) such as carbamazepine and valproate are widely used as alternatives to lithium in bipolar disorder; carbamazepine has its own side effects, notably blood and liver problems, and also requires blood monitoring. Valproate is probably the most widely used drug for this indication in the US. It does not usually need blood monitoring. These drugs raise the risk of malformations in the foetus, which is discussed below.

Minor tranquillisers

Minor tranquillisers, such as the benzodiazepines, the best known of which is diazepam (trade name Valium), are less frequently prescribed these days because of the risk of addiction (see below). (Alternatives for patients requiring short-term medication treatment for agitation or insomnia include small doses of antihistamines.)

Stimulants

Stimulants are used to treat the controversial condition ‘attention deficit hyperactivity disorder’, ADHD, in children. They are intended for short-term use as part of a multidisciplinary treatment programme, but because of shortages of resources in child and adolescent mental health services, there is frequently pressure from various parties, including schools, to prescribe for long periods. The best known drug is Ritalin, the trade name for methylphenidate, which is a kind of mild amphetamine. They are not currently licensed for this indication for use in adults in the UK.

It seems to the authors that there is something intrinsically contradictory in the use of stimulant drugs to treat a condition defined by overactivity. The ‘condition’ may well be partly due to changes in children's lifestyles, in particular, reduction in physical exercise, and the increasing use of television, videos, computers, computer games etc. These drugs are being heavily promoted, on both sides of the Atlantic, and it is possible that future years will see re-examination of the basis for their widespread prescription not only in medical circles, but also possibly in legal ones.

Acetyl cholinesterase inhibitors

Acetyl cholinesterase inhibitors are used in Alzheimer's disease and other kinds of dementia. There has been controversy about their availability in some circumstances in some parts of the UK, but not England. They can to some extent slow disease progression, and help delay need for institutional care.

Psychological treatments

Psychological treatments are popular with patients, and also fashionable; a government minister, Lord Layard, went so far as to propose mass availability of cognitive behaviour therapy (CBT), the most favoured form currently, in dedicated ‘psychological treatment centres’, though it is presently unclear whether, or to what extent, this is going to be implemented, though pilot schemes of Improving Access to Psychiological Treatment (IAPT) are underway. IAPT may encourage the employment of “graduate workers”, typically psychology graduates, who are given basic training in CBT, especially computerised CBT (see below), and employed in Enhanced Primary Care Mental Health Teams.

A great deal of counselling is done in primary care, and although there is little hard evidence of clinical effectiveness, it is popular with patients, who see it as preferable to ‘drugging the problem’. In fact, most such mild problems would probably resolve with the passage of time in any case. For significant degrees of anxiety and depression, the evidence is that medication combined with psychological treatment is superior to either alone.

Cognitive behavioural therapy is a form of psychological treatment, which has evidence of effectiveness across a range of mental health problems. The treatment combines cognitive therapy and behavioural therapy. Cognitive therapy is based on the idea that repeated patterns of thinking can influence mood, and that organised efforts to change thought patterns can improve mood. Behavioural therapy is based on the idea that increasing activity can improve confidence and reduce symptoms, for example, ‘getting back on the horse’, if one has had a fall. CBT for depression, therefore, might involve half a dozen individual sessions with a therapist, starting with the development of a shared understanding of the current problems, setting goals for therapy, and their achievement progressively through thought exercises and activity scheduling, progress being monitored by the keeping of written records.

Such systemised therapy is obviously well adapted to the use of the written word, and schemes of ‘books on prescription,’ sometimes dignified with the name of bibliotherapy, are widespread and seem acceptable to patients. Computerised therapy is also increasingly available. Other forms of therapy such as the traditional psychoanalytic therapy, deriving from the work of Freud and successors, are now, generally regarded as not evidence-based, and are accordingly less and less available in the NHS.

Occupational therapy

Occupational therapy has a long history, and when it was in the form of real work was likely helpful to many patients. Occupational therapists have followed patients out of the hospitals into the community mental health teams, where they often run groups, for example to help patients with self-esteem or assertiveness, and help particularly in rehabilitation back into employment.



Mental Disorders
 alcohol misuse

 anxiety & PTSD

 CBT & psychotherapy

 dementia & delirium

 depression

 drug misuse

 drug treatment

 eating disorders

 ECT & psychosurgery

 medication

 mental health services

 old age psychiatry

 paranoid states

 personality disorder

 prognosis

 psychological treatment

 schizophrenia

 sexual problems

 suicide and self-harm

 women's health

 
       
       
psychiatryforlawyers.com   home  feedback  the author  reports  training  contact    
IMPORTANT DISCLAIMER This website is provided in good faith for general information only, based on Dr Gill's understanding of psychiatry in the UK. It does not represent the views of any organisation with which he has a relationship. It is not to be taken as advice or opinion on any specific case or issue whatsoever. In particular, material provided about the method of assessment in medicolegal cases or about any other matters is not to be taken out of context. Opinion expressed by Dr. Gill in an individual medicolegal case and method of assessment may adhere to or depart from the material on this website entirely according to his professional judgement. Nothing on this website forms part of his terms and conditions for medicolegal work, let alone part of his reports. Nor does Dr. Gill holds himself out as an authority on these matters. Other views undoubtedly exist on most if not all matters covered, which may be just as valid as his. No liability is accepted for any use of this website, or for any error or omission. By using the site, you agree to these terms. The text partly derives from Outline of Psychiatry, a textbook originated by Dr Jenny Barroclough, later prepared jointly, and the most recent edition by Dr Gill.


 
Copyright © Dr David Gill. All rights reserved.